ALIAS (Albumin in Acute Ischemic Stroke) trials: analysis of the combined data from parts 1 and 2. 234. Guluma KZ, Liebeskind DS, Raman R, Rapp KS, Ernstrom KB, Alexandrov AV, Shahripour RB, Barlinn K, Starkman S, Grunberg ID, et al. Feasibility and safety of using external counterpulsation to augment cerebral blood flow in acute ischemic stroke: the Counterpulsation to UpgradeForwardFlowinStroke(CUFFS)Trial.JStrokeCerebrovascDis. 235. Saver JL, Starkman S, Eckstein M, Stratton SJ, Pratt FD, Hamilton S, Conwit R, Liebeskind DS, Sung G, Kramer I, et al; FAST- MAG Investigators and Coordinators. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med. 2015;372:528 236. Lapchak PA. Taking a light approach to treating acute ischemic stroke patients: transcranial near-infrared laser therapy translational science. Ann Med. 2010;42:576 586. doi: 10.3109/07853890.2010.532811 237. StemerAB, Huisa BN, Zivin JA. The evolution of transcranial laser therapy 238. Zivin JA, Albers GW, Bornstein N, Chippendale T, Dahlof B, Devlin T, Fisher M, Hacke W, Holt W, Ilic S, et al; for the NeuroThera Effectiveness and Safety Trial-2 Investigators. Effectiveness and safety of transcranial laser therapy for acute ischemic stroke. Stroke. 2009;40:1359 1364. doi: 239. Hacke W, Schellinger PD, Albers GW, Bornstein NM, Dahlof BL, Fulton R, Kasner SE, Shuaib A, Richieri SP, Dilly SG, et al; for the NEST 3 Committees and Investigators. Transcranial laser therapy in acute stroke treatment: results of Neurothera Effectiveness and Safety Trial 3, a phase III clinical end point device trial. Stroke. 2014;45:3187 240. Anderson CS, Arima H, Lavados P, Billot L, Hackett ML, Olavarr a VV, Mu oz Venturelli P, Brunser A, Peng B, Cui L, et al; HeadPoSTInvestigatorsandCoordinators.Cluster-randomized,crossover trial of head positioning in acute stroke. N Engl J Med. 2017;376:2437 241. 